|Title||Medical management of the pregnant patient with inflammatory bowel disease.|
|Publication Type||Journal Article|
|Year of Publication||2004|
|Authors||Steinlauf AF, Present DH|
|Journal||Gastroenterol Clin North Am|
|Date Published||2004 Jun|
|Keywords||6-Mercaptopurine, Adrenal Cortex Hormones, Anti-Bacterial Agents, Anti-Inflammatory Agents, Non-Steroidal, Antibodies, Monoclonal, Azathioprine, Female, Humans, Immunosuppressive Agents, Inflammatory Bowel Diseases, Pregnancy, Pregnancy Complications|
Gastroenterologists are not infrequently faced with questions regarding pregnancy when advising or treating their patients with inflammatory bowel disease (IBD). To advise patients effectively, the following factors must be considered: (1) the inheritance patterns of IBD for accurate counseling and family planning; (2) the effects of active IBD versus medications or surgery on fertility; (3) the effects of pregnancy on the course of IBD; (4) the effects and potential risks of active IBD versus those of diagnostic tests, medical treatments, and surgical treatments on the developing fetus; (5) approach to delivery; and (6) the risks of breast-feeding while receiving treatment for IBD.
|Alternate Journal||Gastroenterol. Clin. North Am.|
Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.